Tryp Therapeutics Has Completed Psychotherapist Training for a Planned Clinical Trial to Investigate Psilocybin Therapy for IBS
Business, Research
Tryp completes their Phase 2a psilocybin for IBS clinical trial training for psychotherapists at Massachusetts General Hospital.
The absolute and relative effect sizes in the 2021 study are not terribly convincing. I would also question some of the control variables used. I say this not to de-emphasize the utility of psychedelics in improving health, but rather to say that these types of studies are somewhat deceptive when presented to consumers of information without a research background. I would recommend sharing these studies, but to be sure to accurately portray them – saying more than just “more research is needed.” Integrity in providing info to the public will go far in the long run to uphold the science of psychedelic research when so many forces seek to discredit it.
Respectfully,
Marsha N. Sargeant, M.S., Ph.D.